{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:37:33Z","timestamp":1791067053975,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.eplepsyres.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T06:01:26Z","timestamp":1428559286000},"page":"44-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Antiepileptic drug use for treatment of epilepsy and dyslipidemia: Systematic review"],"prefix":"10.1016","volume":"113","author":[{"given":"Manav V.","family":"Vyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Andrew","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Escalaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Costella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Saposnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge G.","family":"Burneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-1211(02)00153-5","article-title":"The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs","volume":"51","author":"Apeland","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1157.1997.tb01128.x","article-title":"Quality of life of people with epilepsy: a European study","volume":"38","author":"Baker","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1528-1167.2009.02303.x","article-title":"Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs","volume":"51","author":"Belcastro","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.seizure.2005.11.008","article-title":"Serum ghrelin levels are enhanced in patients with epilepsy","volume":"15","author":"Berilgen","year":"2006","journal-title":"Seizure J. Br. Epilepsy Assoc."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1600-0404.1982.tb06852.x","article-title":"Serum lipids and anticonvulsants","volume":"66","author":"Berlit","year":"1982","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1991.tb04691.x","article-title":"Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital","volume":"83","author":"Calandre","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1528-1157.1992.tb02299.x","article-title":"The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients","volume":"33","author":"Calandre","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0040","first-page":"e5","article-title":"Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents","volume":"17","author":"Cheng","year":"2010","journal-title":"Can. J. Clin. Pharmacol. J. Can. Pharmacol. Clin."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1528-1157.1987.tb03641.x","article-title":"Effect of prolonged anticonvulsant medication in epileptic patients: serum lipids, vitamins B6, B12, and folic acid, proteins, and fine structure of liver","volume":"28","author":"Dastur","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bmj.316.7125.140","article-title":"Spurious precision? Meta-analysis of observational studies","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2007.07.005","article-title":"Cardiovascular risk factors and homocysteine in epilepsy","volume":"76","author":"Elliott","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.yebeh.2008.04.003","article-title":"Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005","volume":"13","author":"Elliott","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00002826-199404000-00010","article-title":"Effect of chronic antiepileptic treatment on biochemical parameters","volume":"17","author":"Erminio","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0075","first-page":"1256","article-title":"Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment","volume":"17","author":"Genc","year":"2010","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0080","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11745-002-1016-x","article-title":"The role of cytochrome P450 in the regulation of cholesterol biosynthesis","volume":"37","author":"Gibbons","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5812\/ircmj.9690","article-title":"Serum level of homocysteine, folate and vitamin-B12 in epileptic patients under carbamazepine and sodium valproate treatment: a systematic review and meta-analysis","volume":"15","author":"Gorjipour","year":"2013","journal-title":"Iran. Red Crescent Med."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ypmed.2010.03.012","article-title":"Why should population attributable fractions be periodically recalculated? An example from cardiovascular risk estimation in southern Europe","volume":"51","author":"Grau","year":"2010","journal-title":"Prev. Med."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","article-title":"Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy","volume":"74","author":"Hamed","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eplepsyres.2005.08.004","article-title":"Serum thyroid hormone balance and lipid profile in patients with epilepsy","volume":"66","author":"Hamed","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0105","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","article-title":"Chapter 8: Assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0110","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archneur.1993.00540060030012","article-title":"Serum lipid levels during carbamazepine medication. A prospective study","volume":"50","author":"Isoj\u00e4rvi","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(01)00806-3","article-title":"Altered ovarian function and cardiovascular risk factors in valproate-treated women","volume":"111","author":"Isoj\u00e4rvi","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1734-1140(09)70082-9","article-title":"Atherosclerotic risk among children taking antiepileptic drugs","volume":"61","author":"Jakubus","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jacc.2008.09.041","article-title":"Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study","volume":"53","author":"Karthikeyan","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0130","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/epi.12338","article-title":"Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy","volume":"54","author":"Kim","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0135","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1528-1167.2007.01052.x","article-title":"Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy","volume":"48","author":"Kim","year":"2007","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1016\/j.eplepsyres.2015.03.002_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1528-1157.43.s.6.11.x","article-title":"The global burden of epilepsy","volume":"43","author":"Leonardi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","article-title":"Antiepileptic drugs and markers of vascular risk","volume":"12","author":"Lopinto-Khoury","year":"2010","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0150","first-page":"52","article-title":"Negative effects of long-term carbamazepine treatment on serum lipids in patients switch epilepsy are reversible. Results from a prospective randomised double blind withdrawal study of antiepileptic drugs (AEDS)","volume":"49","author":"Lossius","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0155","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00415-002-0731-3","article-title":"Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women","volume":"249","author":"Luef","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2009.04.004","article-title":"Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment","volume":"86","author":"Luef","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0165","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/00005344-198211000-00023","article-title":"Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in epileptics","volume":"4","author":"Luoma","year":"1982","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0404.1979.tb02951.x","article-title":"Plasma HDL cholesterol in epileptics with elevated triglyceride and cholesterol","volume":"60","author":"Luoma","year":"1979","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000115130","article-title":"Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants","volume":"19","author":"Luoma","year":"1980","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.0954-6820.1979.tb13500.x","article-title":"Changes in serum triglyceride and cholesterol levels during long-term phenytoin treatment for epilepsy","volume":"206","author":"Luoma","year":"1979","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00002018-200124060-00003","article-title":"Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels","volume":"24","author":"Mantel-Teeuwisse","year":"2001","journal-title":"Drug Saf. Int. J. Med. Toxicol. Drug Exp."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/WCO.0b013e32833735e7","article-title":"Metabolic consequences of antiepileptic drugs","volume":"23","author":"Mintzer","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2014.03.008","article-title":"Use of antiepileptic drugs and lipid-lowering agents in the United States","volume":"34","author":"Mintzer","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eplepsyres.2011.10.001","article-title":"Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein","volume":"98","author":"Mintzer","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0920-1211(03)00085-8","article-title":"Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.0954-6820.1978.tb08483.x","article-title":"Elevation of high-density lipoprotein in epileptic patients treated with phenytoin","volume":"204","author":"Nikkil\u00e4","year":"1978","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0225","first-page":"MT50","article-title":"The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy","volume":"10","author":"Nikolaos","year":"2004","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0230","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1528-1157.1997.tb01194.x","article-title":"Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy","volume":"38","author":"Nilsson","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0235","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2186","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0240","first-page":"S186","article-title":"Effects of common anti-epileptic drugs on the serum levels of homocysteine and folic acid","volume":"3","author":"Paknahad","year":"2012","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.4.5988.85","article-title":"Increase in serum cholesterol during phenytoin treatment","volume":"4","author":"Pelkonen","year":"1975","journal-title":"Br. Med. J."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0250","first-page":"1228","article-title":"Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population","volume":"19","author":"Phabphal","year":"2012","journal-title":"Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0255","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","article-title":"Fasting serum insulin and lipid levels in men with epilepsy","volume":"60","author":"Pylv\u00e4nen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0260","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.yebeh.2006.02.008","article-title":"Insulin-related metabolic changes during treatment with valproate in patients with epilepsy","volume":"8","author":"Pylv\u00e4nen","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0074-7742(08)00019-6","article-title":"Metabolic effects of AEDs: impact on body weight, lipids and glucose metabolism","volume":"83","author":"Sheth","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0270","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1528-1157.1999.tb00744.x","article-title":"Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study","volume":"40","author":"Sudhop","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2010.01372.x","article-title":"Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine","author":"Svalheim","year":"2010","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0280","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","article-title":"Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis","volume":"50","author":"Tan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0285","first-page":"258","article-title":"Effects of valproic acid on serum lipoprotein and apolipoprotein in epileptic patients","volume":"40","author":"Vilchez","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.03.002_bib0290","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/BF00208485","article-title":"Changes of serum lipid patterns during long-term anticonvulsive treatment","volume":"71","author":"Zeitlhofer","year":"1993","journal-title":"Clin. Investig."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:32:47Z","timestamp":1760275967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121115000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":58,"alternative-id":["S0920121115000509"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.03.002","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepileptic drug use for treatment of epilepsy and dyslipidemia: Systematic review","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}